mark gordon glutathione R. Gordon, DDS, MS Mark Gordon - NCDMM
Mark Gordon NCDMM EOne Acquires 51% Stake in the Mark Gordon Co. for $133 Million Frontiers Glutathione and neurodegenerative diseases: immunopharmacological implications Dr. Mark Gordon, Surgical Director of the Dickstein Cancer Program White Plains Hospital.
Pay in 4 interest-free payments of $5.48 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22


